Get the app Watchlists Portfolios Alerts Sign in Get started

Menu

DiaMedica Therapeutics Inc. DMAC

Full chart Compare

Set alert

9.04 USD -1.73 (-16.06%)

At closeNov 5, 2026, 4:00 PM EST

9.04 0.00 0.00%

After hours · Nov 5, 4:00 PM ET

8.98 Day range 10.84

5.25 52-week range 11.00

YTD: +13.57%
1 year: +35.94%

News

20 hours ago businesswire.com DiaMedica Therapeutics to Report Third Quarter 2026 Financial Results and Provide a Business Update November 13, 2026 MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for preeclampsia, fetal growth restriction…
2 weeks ago benzinga.com DiaMedica Therapeutics Enrolls 200th Patient In ReMEDy2 Phase 2/3 Acute Ischemic Stroke Trial Independent Data Safety Monitoring Board to Conduct a Pre-Specified Interim Analysis to Assess Need for Sample Size Re-EstimationInterim Analysis Results Expected in Q1 2027